Filing Details
- Accession Number:
- 0001127602-23-001064
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-06 16:04:24
- Reporting Period:
- 2023-01-04
- Accepted Time:
- 2023-01-06 16:04:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1631895 | Shacey Petrovic | C/O Insulet Corporation 100 Nagog Park Acton MA 01720 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-01-04 | 10,445 | $46.22 | 25,234 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-01-04 | 4,555 | $74.50 | 29,789 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-01-04 | 15,000 | $281.88 | 14,789 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2023-01-04 | 10,445 | $0.00 | 10,445 | $46.22 |
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2023-01-04 | 4,555 | $0.00 | 4,555 | $74.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2027-02-22 | No | 4 | M | Direct | |
11,838 | 2028-02-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 73,205 | Indirect | By NG Trust |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.
- The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $278.63 to $289.70. Specifically: 3,144 shares were sold in the range of $278.63 to $279.62, with a weighted average share price of $279.20; 2,556 shares were sold in the range of $279.65 to $280.59, with a weighted average share price of $280.05; 2,337 shares were sold in the range of $280.66 to $281.39, with a weighted average share price of $281.13; 2,775 shares were sold in the range of $281.67 to $282.55, with a weighted average share price of $282.17;
- Footnote continued:898 shares were sold in the range of $282.73 to $283.68, with a weighted average share price of $283.33; 1,184 shares were sold in the range of $283.78 to $284.53, with a weighted average share price of $284.06; 700 shares were sold in the range of $284.82 to $285.18, with a weighted average share price of $284.89; 800 shares were sold in the range of $286.44 to $286.79, with a weighted average share price of $286.66; 300 shares were sold in the range of $287.68 to $288.45, with a weighted average share price of $288.10; 306 shares were sold in the range of $289.25 to $289.70, with a weighted average share price of $289.38. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.